|
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
| 104.40 NOK | -0.57% |
|
-0.76% | +5.78% |
| May. 06 | Aker BioMarine ASA Wins New Lysoveta Contract Valued At USD 4 Million in 2026 | CI |
| May. 06 | Aker BioMarine secures Lysoveta contract | RE |
Main competitors
| P/E (Y) | Price to Book (Y) | PEG (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
 | 60.48x | 5.59x | -0.35x | 4.54x | 19.29x | 33.22x | -.--% | 994M | |
| 32.68x | 2.21x | -0.75x | 1.09x | 11.16x | 28.13x | 0.32% | 14.08B | |
| 7.93x | 0.63x | -0.34x | 1.09x | 8.93x | 15.32x | 5.39% | 4.74B | |
| 28.7x | 3.72x | 15.05x | 1.84x | 13.97x | 19.77x | 1.39% | 3.36B | |
| 12.78x | 1.38x | -0.66x | 1.38x | 6.42x | 8.64x | 1.88% | 2.82B | |
| 12.21x | 1.55x | 0.59x | 2.02x | 6.66x | 9.12x | 5.03% | 1.64B | |
| 7.21x | 1.45x | 1.11x | 0.51x | 4.6x | 5.18x | 5.58% | 1.74B | |
| 18.9x | - | -2.54x | - | - | - | - | 1.56B | |
| -21.76x | 1.48x | 0.07x | 0.73x | - | -58.65x | 1.41% | 1.44B | |
| 8.64x | 1.06x | 1x | - | - | - | - | 1.35B | |
| 10.65x | 0.93x | 0.07x | 0.19x | 4.59x | 6.86x | 2.41% | 1.39B | |
| 9.27x | 1.48x | -1.49x | 2.33x | 5.33x | 6.4x | 3.97% | 958M | |
| 11.59x | - | 0.11x | - | - | - | - | 1.24B | |
| 13.4x | 0.85x | -9.56x | 1.89x | 7.61x | 11.42x | 4.96% | 1.18B | |
| Average | 15.19x | 1.86x | 0.17x | 1.60x | 8.86x | 7.77x | 2.94% | 2.75B | |
| Weighted average by Cap. | 20.43x | 1.91x | 0.63x | 1.31x | 9.82x | 16.34x | 2.13% |
- Stock Market
- Equities
- AKBM Stock
- Sector Aker BioMarine ASA
- Sector valuations
Select your edition
All financial news and data tailored to specific country editions
